We've found
17,797
archived clinical trials in
Peripheral Vascular Disease
We've found
17,797
archived clinical trials in
Peripheral Vascular Disease
The Fibrin Pad CV Phase III Study
Updated: 8/14/2017
A Single-blinded, Randomized, Controlled, Comparative Phase III Study Evaluating the Safety and Effectiveness of EVARREST™ Fibrin Sealant Patch as an Adjunct to Hemostasis During Cardiovascular Surgery
Status: Enrolling
Updated: 8/14/2017
The Fibrin Pad CV Phase III Study
Updated: 8/14/2017
A Single-blinded, Randomized, Controlled, Comparative Phase III Study Evaluating the Safety and Effectiveness of EVARREST™ Fibrin Sealant Patch as an Adjunct to Hemostasis During Cardiovascular Surgery
Status: Enrolling
Updated: 8/14/2017
Click here to add this to my saved trials
The Fibrin Pad CV Phase III Study
Updated: 8/14/2017
A Single-blinded, Randomized, Controlled, Comparative Phase III Study Evaluating the Safety and Effectiveness of EVARREST™ Fibrin Sealant Patch as an Adjunct to Hemostasis During Cardiovascular Surgery
Status: Enrolling
Updated: 8/14/2017
The Fibrin Pad CV Phase III Study
Updated: 8/14/2017
A Single-blinded, Randomized, Controlled, Comparative Phase III Study Evaluating the Safety and Effectiveness of EVARREST™ Fibrin Sealant Patch as an Adjunct to Hemostasis During Cardiovascular Surgery
Status: Enrolling
Updated: 8/14/2017
Click here to add this to my saved trials
The Fibrin Pad CV Phase III Study
Updated: 8/14/2017
A Single-blinded, Randomized, Controlled, Comparative Phase III Study Evaluating the Safety and Effectiveness of EVARREST™ Fibrin Sealant Patch as an Adjunct to Hemostasis During Cardiovascular Surgery
Status: Enrolling
Updated: 8/14/2017
The Fibrin Pad CV Phase III Study
Updated: 8/14/2017
A Single-blinded, Randomized, Controlled, Comparative Phase III Study Evaluating the Safety and Effectiveness of EVARREST™ Fibrin Sealant Patch as an Adjunct to Hemostasis During Cardiovascular Surgery
Status: Enrolling
Updated: 8/14/2017
Click here to add this to my saved trials
The Fibrin Pad CV Phase III Study
Updated: 8/14/2017
A Single-blinded, Randomized, Controlled, Comparative Phase III Study Evaluating the Safety and Effectiveness of EVARREST™ Fibrin Sealant Patch as an Adjunct to Hemostasis During Cardiovascular Surgery
Status: Enrolling
Updated: 8/14/2017
The Fibrin Pad CV Phase III Study
Updated: 8/14/2017
A Single-blinded, Randomized, Controlled, Comparative Phase III Study Evaluating the Safety and Effectiveness of EVARREST™ Fibrin Sealant Patch as an Adjunct to Hemostasis During Cardiovascular Surgery
Status: Enrolling
Updated: 8/14/2017
Click here to add this to my saved trials
The Fibrin Pad CV Phase III Study
Updated: 8/14/2017
A Single-blinded, Randomized, Controlled, Comparative Phase III Study Evaluating the Safety and Effectiveness of EVARREST™ Fibrin Sealant Patch as an Adjunct to Hemostasis During Cardiovascular Surgery
Status: Enrolling
Updated: 8/14/2017
The Fibrin Pad CV Phase III Study
Updated: 8/14/2017
A Single-blinded, Randomized, Controlled, Comparative Phase III Study Evaluating the Safety and Effectiveness of EVARREST™ Fibrin Sealant Patch as an Adjunct to Hemostasis During Cardiovascular Surgery
Status: Enrolling
Updated: 8/14/2017
Click here to add this to my saved trials
The Fibrin Pad CV Phase III Study
Updated: 8/14/2017
A Single-blinded, Randomized, Controlled, Comparative Phase III Study Evaluating the Safety and Effectiveness of EVARREST™ Fibrin Sealant Patch as an Adjunct to Hemostasis During Cardiovascular Surgery
Status: Enrolling
Updated: 8/14/2017
The Fibrin Pad CV Phase III Study
Updated: 8/14/2017
A Single-blinded, Randomized, Controlled, Comparative Phase III Study Evaluating the Safety and Effectiveness of EVARREST™ Fibrin Sealant Patch as an Adjunct to Hemostasis During Cardiovascular Surgery
Status: Enrolling
Updated: 8/14/2017
Click here to add this to my saved trials
Transesophageal Magnetic Resonance Imaging (MRI) in Conjunction With Lipid Lowering Measures
Updated: 8/23/2017
Transesophageal MRI in Conjunction With Lipid Lowering Measures
Status: Enrolling
Updated: 8/23/2017
Transesophageal Magnetic Resonance Imaging (MRI) in Conjunction With Lipid Lowering Measures
Updated: 8/23/2017
Transesophageal MRI in Conjunction With Lipid Lowering Measures
Status: Enrolling
Updated: 8/23/2017
Click here to add this to my saved trials
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Click here to add this to my saved trials
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Click here to add this to my saved trials
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Click here to add this to my saved trials
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Click here to add this to my saved trials
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Click here to add this to my saved trials
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Click here to add this to my saved trials
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Click here to add this to my saved trials
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Click here to add this to my saved trials
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Click here to add this to my saved trials
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Click here to add this to my saved trials
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Click here to add this to my saved trials
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Click here to add this to my saved trials
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Click here to add this to my saved trials
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Click here to add this to my saved trials
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Click here to add this to my saved trials
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Click here to add this to my saved trials
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes
Updated: 8/28/2017
Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes
Status: Enrolling
Updated: 8/28/2017
Click here to add this to my saved trials
Comparative Effectiveness of Decision Aids for Stable Chest Discomfort
Updated: 8/28/2017
Randomized Trial Comparing Effectiveness of Two Patient Decision Aids for Stable Chest Discomfort
Status: Enrolling
Updated: 8/28/2017
Comparative Effectiveness of Decision Aids for Stable Chest Discomfort
Updated: 8/28/2017
Randomized Trial Comparing Effectiveness of Two Patient Decision Aids for Stable Chest Discomfort
Status: Enrolling
Updated: 8/28/2017
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
Updated: 8/29/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
Updated: 8/29/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
Updated: 8/29/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
Updated: 8/29/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
Updated: 8/29/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
Updated: 8/29/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
Updated: 8/29/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
Updated: 8/29/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
Updated: 8/29/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
Updated: 8/29/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
Updated: 8/29/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
Updated: 8/29/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
Updated: 8/29/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
Updated: 8/29/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
Updated: 8/29/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
Updated: 8/29/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
Updated: 8/29/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
Updated: 8/29/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
Updated: 9/5/2017
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Click here to add this to my saved trials